Controlled colonization of the human gut with a genetically engineered microbial medicine
Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
Precision microbiome programming for therapeutic applications has been limited by challenges in achieving reproducible colonization of the colon. Previously, we used a porphyran prebiotic to create a synthetic niche to engraft engineered bacteria into diverse microbiota in mice. Here we extend that work with biocontainment that links essential gene expression to porphyran presence yielding a platform for controlled colonization and decolonization of humans with engineered Bacteroides . We engineered this chassis with a five-gene oxalate degradation pathway, creating a therapeutic candidate that reduces hyperoxaluria, a cause of kidney stones, in pre-clinical models. Our Phase 1/2a clinical trial demonstrates tunable and reversible engraftment in humans, shows promising oxalate reductions, highlights addressable challenges in this novel modality for therapeutics, and queries key questions in microbiome science.
